-
Sponsored by MaiwaldKerstin Wolff of Maiwald explains how the EU’s provisional agreement on plants generated by new genomic techniques divides them into two categories, opening the market while preserving patent and regulatory oversight -
Sponsored by MaiwaldSenior intellectual property practitioners from Maiwald discuss how innovators can secure robust patent protection for AI inventions amid evolving EPO practice and accelerating technological change
-
Sponsored by CCPIT Patent and Trademark Law OfficeThe revised Patent Examination Guidelines foster innovation by redefining plant varieties, says Juhua Luo of CCPIT Patent and Trademark Law Office
-
Sponsored by Bird & BirdFame means not all literary figure marks are created equal, says Charlotte Colthurst of Bird & Bird in examining an EUIPO Grand Board of Appeal ruling
-
Sponsored by Becerril, Coca & BecerrilStephania Cardiel of Becerril, Coca & Becerril examines how recent reforms signal a regional move towards faster, more internationally aligned innovation systems
-
Sponsored by INLEXPravir Palayathan of INLEX explains Mauritius’ customs-led system for protecting trademarks, regulating authorised importers and exporters, and swiftly seizing counterfeit goods
-
Sponsored by CCPIT Patent and Trademark Law OfficeNew CNIPA examination practices on non-use cancellation raise evidentiary requirements for petitioners. Ling Zhao of CCPIT Patent and Trademark Law Office highlights the implications for registrants and enforcement strategies in China
-
Sponsored by That.LegalGillian Tan of That.Legal explains how accidental font licensing gaps arise in practice, and how Singapore’s compensatory copyright framework affects enforcement outcomes
-
Sponsored by INLEXIgor Charles of INLEX explains how the EUIPO Board of Appeal recognised the Givenchy 4G logo’s reputation in France, linking luxury goods to financial services under Article 8(5) of the EU Trademark Regulation
-
Sponsored by Wanhuida Intellectual PropertyYue Guan of Wanhuida Intellectual Property explains how the CNIPA’s rulings on mirogabalin besylate tablets highlight the importance of formulation patent drafting and claim amendments in China’s drug patent landscape
-
Sponsored by Tilleke & GibbinsRights holders with interests in Vietnam should pay heed to the substantial changes, say Linh Duy Mai and Giang Hoang Bach of T&G Law Firm LLC (TGVN), the local associate of Tilleke & Gibbins
-
Sponsored by Tilleke & GibbinsThanh Phuong Vu of Tilleke & Gibbins explains how Vietnam’s 2025 Intellectual Property Law amendment introduces protection for partial and intangible designs under Locarno Class 32
